1. Home
  2. IDAI vs BFRI Comparison

IDAI vs BFRI Comparison

Compare IDAI & BFRI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo T Stamp Inc.

IDAI

T Stamp Inc.

HOLD

Current Price

$2.37

Market Cap

12.5M

Sector

Technology

ML Signal

HOLD

Logo Biofrontera Inc.

BFRI

Biofrontera Inc.

HOLD

Current Price

$0.85

Market Cap

10.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
IDAI
BFRI
Founded
2016
1997
Country
United States
United States
Employees
96
93
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
12.5M
10.6M
IPO Year
2022
N/A

Fundamental Metrics

Financial Performance
Metric
IDAI
BFRI
Price
$2.37
$0.85
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
1
Target Price
$12.00
$2.75
AVG Volume (30 Days)
75.0K
131.0K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$3.46
$11.37
Revenue Next Year
$99.91
$10.96
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.43
$0.54
52 Week High
$5.28
$1.18

Technical Indicators

Market Signals
Indicator
IDAI
BFRI
Relative Strength Index (RSI) 36.63 49.35
Support Level $1.90 $0.81
Resistance Level $3.13 $0.89
Average True Range (ATR) 0.25 0.04
MACD 0.02 -0.00
Stochastic Oscillator 23.15 39.39

Price Performance

Historical Comparison
IDAI
BFRI

About IDAI T Stamp Inc.

T Stamp Inc develops and markets identity authentication software solutions for enterprise partners and peer-to-peer markets. The company is engaged in developing proprietary artificial intelligence-powered solutions; researching and leveraging biometric science, cryptography, and data mining to deliver insightful identity & trust predictions while identifying and defending against fraudulent identity attacks, protecting sensitive user information, and extending the reach of digital services through accessibility. The artificial intelligence-powered solutions segment generates revenue principally from software licenses, professional services, and recurring Software-as-a-Service ("SaaS") revenue.

About BFRI Biofrontera Inc.

Biofrontera Inc is a United States-based biopharmaceutical company commercializing a portfolio of pharmaceutical products for the treatment of dermatological conditions with a focus on photodynamic therapy. The Company's licensed products, which include Ameluz as well as the BF-RhodoLED and RhodoLED XL lamps (together, the RhodoLED Lamps), are used for the treatment of actinic keratoses (AKs), which are pre-cancerous skin lesions.

Share on Social Networks: